Berkeley Capital Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Berkeley Capital Partners's GILD Position: Q3 2026 in Review
Berkeley Capital Partners held its Gilead Sciences (GILD) position steady in Q3 2026 at 2,064 shares worth $308K. The position accounts for 0.06% of the portfolio, ranked #156.
Berkeley Capital Partners first reported a position in GILD in Q4 2015 and has held it in 10 quarters since. The position peaked at $798K in Q1 2020. 2,357 funds tracked by Wall St. Rank hold GILD as of Q3 2026.
- Berkeley Capital Partners held 2,064 shares of Gilead Sciences worth $308K as of Q3 2026.
- Berkeley Capital Partners left its Gilead Sciences share count unchanged in Q3 2026.
- Gilead Sciences made up 0.06% of Berkeley Capital Partners's portfolio in Q3 2026, its #156 holding.
- Berkeley Capital Partners first reported a position in Gilead Sciences in Q4 2015 and has held it in 10 quarters since.
- Berkeley Capital Partners's Gilead Sciences position peaked at $798K in Q1 2020.
- 2,357 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.
Based on Berkeley Capital Partners's 13F filing for Q3 2026, filed 12 Nov 2026.